埃斯库莱揭示了:通过分子机制解读其抗瘤潜力 - - 一个全面的审查
Md Rezoan Hossain1, Fatema Tuj Zahra Shova2, Munni Akter3
1Biochemistry and Molecular Biology, Rajshahi University, Rajshahi, Bangladesh.
Cancer reports (Hoboken, N.J.)
|December 8, 2023
概括
斯库莱是一种天然化合物,通过调节关键细胞过程,对16种癌症类型表现出显著的抗癌活性. 它的纳米配方和协同效应提高了疗效,减少了副作用,将其定位为有前途的癌症治疗方法.
科学领域:
- 自然产品化学 自然产品化学
- 药理学 药理学是指药理学的学科.
- 在瘤学瘤学.
背景情况:
- 癌症的复杂性需要新的治疗策略.
- 现有的治疗方法面临着包括副作用在内的局限性.
- 天然化合物提供了具有更好的安全概况的替代方法.
研究的目的:
- 综合审查埃斯库莱的抗癌性质.
- 详细介绍其分子和细胞作用机制.
- 评估其作为癌症治疗的潜力.
主要方法:
- 关于 esculetin 的体内和体外研究的文献综述.
- 对 Esculetin 对癌症特征的影响的分析.
- 纳米配方和协同战略的研究.
主要成果:
- 埃斯库莱丁对16种癌症类型表现出有效性.
- 它调节关键通路,包括增殖,亡和血管生成.
- 纳米配方增强了溶解性和有效性;协同使用逆转了耐药性.
结论:
- 埃斯库莱显示出广泛的抗癌活性.
- 它具有有利的药理动力学和安全性概况.
- 埃斯库莱是癌症治疗的有希望的候选者.
相关概念视频
Drugs that Stabilize Microtubules
2.1K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


